Literature DB >> 24974066

Health outcomes of pediatric rheumatic diseases.

Nadia J C Luca1, Brian M Feldman2.   

Abstract

Measurement of health outcomes in pediatric rheumatic diseases is a critical component of clinical practice and research studies. Measures should include the biological, physical, and psychosocial dimensions of health. Health outcome measures are developed systematically, often using consensus methods. Prior to implementation into practice, health outcome measures must undergo evaluation of measurement properties such as reliability, validity, and responsiveness. There are several health outcome measures available for juvenile idiopathic arthritis, juvenile systemic lupus erythematosus, and juvenile dermatomyositis, many of which are composite measures of disease activity. In addition, tools exist for measuring physical functioning and health-related quality of life. There is increasing focus on the incorporation of patient-reported or parent-reported outcomes when measuring the health state of patients with pediatric rheumatic diseases. Further work is required to determine the optimal health outcome measures and approach for eliciting the patient's perception of their health state in pediatric rheumatology.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Consensus development; Criteria; Juvenile dermatomyositis; Juvenile idiopathic arthritis; Juvenile systemic lupus erythematosus; Outcome assessment

Mesh:

Year:  2014        PMID: 24974066     DOI: 10.1016/j.berh.2014.04.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  11 in total

Review 1.  Improving care delivery and outcomes in pediatric rheumatic diseases.

Authors:  Julia G Harris; Catherine A Bingham; Esi M Morgan
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

Review 2.  Using Patient-Reported Outcome Measures to Capture the Patient's Voice in Research and Care of Juvenile Idiopathic Arthritis.

Authors:  Aimee O Hersh; Parissa K Salimian; Elissa R Weitzman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-18       Impact factor: 2.670

3.  Patient-reported Outcomes across Categories of Juvenile Idiopathic Arthritis.

Authors:  Alysha J Taxter; E Paul Wileyto; Edward M Behrens; Pamela F Weiss
Journal:  J Rheumatol       Date:  2015-09-01       Impact factor: 4.666

Review 4.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

Review 5.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

6.  Health-related quality of life in children with juvenile idiopathic arthritis - child's and parent's point of view.

Authors:  Małgorzata Mańczak; Lidia Rutkowska-Sak; Filip Raciborski
Journal:  Reumatologia       Date:  2016-11-28

Review 7.  Juvenile Idiopathic Arthritis: Diagnosis and Treatment.

Authors:  Gabriella Giancane; Alessandro Consolaro; Stefano Lanni; Sergio Davì; Benedetta Schiappapietra; Angelo Ravelli
Journal:  Rheumatol Ther       Date:  2016-08-12

8.  Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.

Authors:  Liza J McCann; Clarissa A Pilkington; Adam M Huber; Angelo Ravelli; Duncan Appelbe; Jamie J Kirkham; Paula R Williamson; Amita Aggarwal; Lisa Christopher-Stine; Tamas Constantin; Brian M Feldman; Ingrid Lundberg; Sue Maillard; Pernille Mathiesen; Ruth Murphy; Lauren M Pachman; Ann M Reed; Lisa G Rider; Annet van Royen-Kerkof; Ricardo Russo; Stefan Spinty; Lucy R Wedderburn; Michael W Beresford
Journal:  Ann Rheum Dis       Date:  2017-10-30       Impact factor: 19.103

Review 9.  Consensus-based recommendations for the management of juvenile dermatomyositis.

Authors:  Felicitas Bellutti Enders; Brigitte Bader-Meunier; Eileen Baildam; Tamas Constantin; Pavla Dolezalova; Brian M Feldman; Pekka Lahdenne; Bo Magnusson; Kiran Nistala; Seza Ozen; Clarissa Pilkington; Angelo Ravelli; Ricardo Russo; Yosef Uziel; Marco van Brussel; Janjaap van der Net; Sebastiaan Vastert; Lucy R Wedderburn; Nicolaas Wulffraat; Liza J McCann; Annet van Royen-Kerkhof
Journal:  Ann Rheum Dis       Date:  2016-08-11       Impact factor: 19.103

10.  Adding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritis.

Authors:  Elissa R Weitzman; Lauren E Wisk; Parissa K Salimian; Kara M Magane; Fatma Dedeoglu; Aimee O Hersh; Yukiko Kimura; Kenneth D Mandl; Sarah Ringold; Marc Natter
Journal:  J Patient Rep Outcomes       Date:  2018-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.